Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?

被引:164
作者
Cheng, Vincent C. C. [1 ,2 ,6 ,7 ]
To, Kelvin K. W. [1 ,4 ,6 ]
Tse, Herman [1 ,4 ,6 ,7 ]
Hung, Ivan F. N. [4 ,5 ]
Yuen, Kwok-Yung [1 ,3 ,4 ,6 ]
机构
[1] Queen Mary Hosp, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[2] Queen Mary Hosp, Infect Control Team, Hong Kong, Hong Kong, Peoples R China
[3] Queen Mary Hosp, Clin Diagnost Microbiol Serv, Hong Kong, Hong Kong, Peoples R China
[4] Univ Hong Kong, Carol Yu Ctr Infect, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China
[5] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[6] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China
[7] Univ Hong Kong, Fac Med, Hong Kong, Hong Kong, Peoples R China
关键词
A H1N1 VIRUS; SWINE-ORIGIN; 2009; EXTRACORPOREAL MEMBRANE-OXYGENATION; HEALTH-CARE WORKERS; RAPID ANTIGEN TEST; NEW-YORK-CITY; RESPIRATORY SYNDROME CORONAVIRUS; REACTIVE NEUTRALIZING ANTIBODY; HOSPITALIZED ADULT PATIENTS; OSELTAMIVIR-RESISTANT;
D O I
10.1128/CMR.05012-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The world had been anticipating another influenza pandemic since the last one in 1968. The pandemic influenza A H1N1 2009 virus (A/2009/H1N1) finally arrived, causing the first pandemic influenza of the new millennium, which has affected over 214 countries and caused over 18,449 deaths. Because of the persistent threat from the A/H5N1 virus since 1997 and the outbreak of the severe acute respiratory syndrome (SARS) coronavirus in 2003, medical and scientific communities have been more prepared in mindset and infrastructure. This preparedness has allowed for rapid and effective research on the epidemiological, clinical, pathological, immunological, virological, and other basic scientific aspects of the disease, with impacts on its control. A PubMed search using the keywords "pandemic influenza virus H1N1 2009" yielded over 2,500 publications, which markedly exceeded the number published on previous pandemics. Only representative works with relevance to clinical microbiology and infectious diseases are reviewed in this article. A significant increase in the understanding of this virus and the disease within such a short amount of time has allowed for the timely development of diagnostic tests, treatments, and preventive measures. These findings could prove useful for future randomized controlled clinical trials and the epidemiological control of future pandemics. © 2012, American Society for Microbiology. All Rights Reserved.
引用
收藏
页码:223 / 263
页数:41
相关论文
共 591 条
  • [51] Fulminant Myocarditis Associated With Pandemic H1N1 Influenza A Virus in Children
    Bratincsak, Andras
    El-Said, Howaida G.
    Bradley, John S.
    Shayan, Katayoon
    Grossfeld, Paul D.
    Cannavino, Christopher R.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (09) : 928 - 929
  • [52] Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease
    Brett, Stephen J.
    Myles, Puja
    Lim, Wei Shen
    Enstone, Joanne E.
    Bannister, Barbara
    Semple, Malcolm G.
    Read, Robert C.
    Taylor, Bruce L.
    McMenamin, Jim
    Nicholson, Karl G.
    Nguyen-Van-Tam, Jonathan S.
    Openshaw, Peter J. M.
    [J]. PLOS ONE, 2011, 6 (04):
  • [53] Risk of influenza A (H5N1) infection among poultry workers, Hong Kong, 1997-1998
    Bridges, CB
    Lim, W
    Hu-Primmer, J
    Sims, L
    Fukuda, K
    Mak, KH
    Rowe, T
    Thompson, WW
    Conn, L
    Lu, XH
    Cox, NJ
    Katz, JM
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (08) : 1005 - 1010
  • [54] Seroprevalence to Influenza A(H1N1) 2009 Virus-Where Are We?
    Broberg, Eeva
    Nicoll, Angus
    Amato-Gauci, Andrew
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (08) : 1205 - 1212
  • [55] Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness
    Brookes, Daniel W.
    Miah, Shahajahan
    Lackenby, Angie
    Hartgroves, Lorian
    Barclay, Wendy S.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2011, 66 (03) : 466 - 470
  • [56] Zanamivir, at 600 Milligrams Twice Daily, Inhibits Oseltamivir-Resistant 2009 Pandemic H1N1 Influenza Virus in an In Vitro Hollow-Fiber Infection Model System
    Brown, Ashley N.
    McSharry, James J.
    Weng, Qingmei
    Adams, Jonathan R.
    Kulawy, Robert
    Drusano, George L.
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (04) : 1740 - 1746
  • [57] Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome
    Brun-Buisson, Christian
    Richard, Jean-Christophe M.
    Mercat, Alain
    Thiebaut, Anne C. M.
    Brochard, Laurent
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183 (09) : 1200 - 1206
  • [58] Pandemic H1N1 Influenza Infection and Vascular Thrombosis
    Bunce, Paul E.
    High, Sasha M.
    Nadjafi, Maral
    Stanley, Katherine
    Liles, W. Conrad
    Christian, Michael D.
    [J]. CLINICAL INFECTIOUS DISEASES, 2011, 52 (02) : E14 - E17
  • [59] PB2 Residue 271 Plays a Key Role in Enhanced Polymerase Activity of Influenza A Viruses in Mammalian Host Cells
    Bussey, Kendra A.
    Bousse, Tatiana L.
    Desmet, Emily A.
    Kim, Baek
    Takimoto, Toru
    [J]. JOURNAL OF VIROLOGY, 2010, 84 (09) : 4395 - 4406
  • [60] Patchy pig monitoring may hide flu threat
    Butler, Declan
    [J]. NATURE, 2009, 459 (7249) : 894 - 895